Cipla Limited — Formoterol Exporter Profile
Indian Pharmaceutical Exporter · #1 for Formoterol · $25.3M export value · DGFT Verified
Cipla Limited is the #1 Indian exporter of Formoterol with $25.3M in export value and 572 verified shipments. Cipla Limited holds a 44.1% market share in Formoterol exports across 25 countries. The company exports 98 pharmaceutical products worth $1.1B across 26 therapeutic categories.
Cipla Limited — Formoterol Export Profile: Buyers & Destinations
Where Does Cipla Limited Export Formoterol?
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $4.6M | 123 | 33.6% |
| SRI LANKA | $2.8M | 89 | 20.3% |
| BELGIUM | $2.5M | 223 | 17.7% |
| ALGERIA | $902.6K | 20 | 6.5% |
| MAURITIUS | $408.3K | 15 | 3.0% |
| YEMEN | $395.3K | 10 | 2.9% |
| FINLAND | $313.0K | 7 | 2.3% |
| TURKEY | $280.0K | 6 | 2.0% |
| OMAN | $219.6K | 9 | 1.6% |
| KENYA | $182.6K | 11 | 1.3% |
Cipla Limited exports Formoterol to 27 countries. The largest destination is UNITED STATES accounting for 33.6% of Cipla Limited's Formoterol shipments, followed by SRI LANKA (20.3%) and BELGIUM (17.7%). These destinations reflect Cipla Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Formoterol from Cipla Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| CIPLA USA INC UPS SUPPLY CHAIN SOLU | UNITED STATES | $4.6M | 120 |
| BREATHEFREE LANKA PVT LTD | SRI LANKA | $2.1M | 69 |
| H.ESSERS & ZONEN INTERNATIONAL TRA | BELGIUM | $1.1M | 92 |
| H.ESSERS & ZONEN INTERNATIONAL TRAN | BELGIUM | $1.0M | 104 |
| BREATHEFREE LANKA PRIVATE LIMITED | SRI LANKA | $674.0K | 20 |
| BIOPHARM DISTRIBUTION SPA | ALGERIA | $500.0K | 10 |
| H ESSERS ZONEN INTERNATIONAL TRA | BELGIUM | $289.6K | 27 |
| MEDICA PHARMACEUTICAL INDUSTRIES L | YEMEN | $233.4K | 6 |
| ORION CORPORATION. | FINLAND | $232.2K | 5 |
| CAPITAL PHARMACY | OMAN | $219.6K | 9 |
Cipla Limited supplies Formoterol to 55 buyers globally. The largest buyer is CIPLA USA INC UPS SUPPLY CHAIN SOLU (UNITED STATES), followed by BREATHEFREE LANKA PVT LTD (SRI LANKA) and H.ESSERS & ZONEN INTERNATIONAL TRA (BELGIUM). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Formoterol Export Value and How Much Does Cipla Limited Contribute?
India exported $39.0M worth of Formoterol through 4,917 shipments from 153 suppliers to 81 countries, serving 320 buyers globally. Cipla Limited contributes $25.3M to this total, accounting for 44.1% of India's Formoterol exports. Cipla Limited ships Formoterol to 27 countries through 55 buyers.
What Is the Average Shipment Value for Cipla Limited's Formoterol Exports?
Cipla Limited's average Formoterol shipment value is $44.3K per consignment, based on 572 shipments totaling $25.3M. The largest destination is UNITED STATES (33.6% of Cipla Limited's Formoterol exports).
How Does Cipla Limited Compare to Other Indian Formoterol Exporters?
Cipla Limited ranks #1 among 153 Indian Formoterol exporters with a 44.1% market share. The top 3 exporters are CIPLA LIMITED ($25.3M), MANKIND PHARMA LIMITED ($8.6M), SUN PHARMACEUTICAL INDUSTRIES LIMITED ($1.8M). Cipla Limited processed 572 shipments to 25 destination countries.
What Formoterol Formulations Does Cipla Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| ARFORMOTEROL TARTRATE INHALATION SOLUTIO | $3.0M | 83 |
| FORACORT 400 DP CAPS (FORMOTEROL FUMARAT | $386.7K | 10 |
| BECLOMETASON/FORMOTEROL CIPLA 100 MIKROGRAMM/6 MIKROGRAMM PRO SPRUHSTOB DRUCKGASINHALATION, LOSUNG (BECLOMETA | $377.3K | 35 |
| BECLOMETASONE DIPROPIONATE /FORMOTEROL FUMARATE DIHYDRATE 100MCG/6 MCG PRESSURISED INHALATION SOLUTION (PS:1X120MD)NOS | $305.8K | 24 |
| FORACORT HFA 200 INHALER + (FORMOTEROL F | $260.4K | 6 |
| FORACORT 200 DP-CAPS (FORMOTEROL FUMARAT | $205.1K | 18 |
| ARFORMOTEROL TARTRATE INHALATION SOLUTION 15MCG/2ML;NDC No.69097-168-64;ANDA No.207306(PS:12X5X2MLX2880 PAC=172800 NOS) | $200.0K | 4 |
| BECLOMETASON/FORMOTEROL CIPLA 100MIKROGRAMM/6 MIKROGRAMM PROSPRUHSTOB DRUCKGASINHALATION, LOSUNG(BECLOMETASON | $188.5K | 15 |
| FORACORT400 DP CAPS (FORMOTEROL FUMARATE | $183.9K | 4 |
| BECLOMETASONE DIPROPIONATE /FORMOTEROL FUMARATE DIHYDRATE 100MCG/6 MCG PRESSURISED INHALATION SOLUTION [P/S:1X120 MD] | $156.9K | 15 |
Cipla Limited exports 214 distinct Formoterol formulations including tablets, capsules, syrups, and combination drugs. The top formulation is ARFORMOTEROL TARTRATE INHALATION SOLUTIO with 83 shipments worth $3.0M.
Regulatory Requirements: Exporting Formoterol to Key Markets
What Cipla Limited must comply with to export Formoterol to its top destination countries
United States — FDA
Approval Process
ANDA (Abbreviated New Drug Application) for generics. Indian manufacturing site must pass FDA pre-approval inspection. Drug Master File (DMF) required for APIs.
Timeline: 10–18 months for ANDA approval
GMP & Export Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA
Drug Listing with FDA; Export Certificate from CDSCO India; Import Alert screening via FDA PREDICT system
Note: Subject to FDA Import Alerts. Open Form 483 observations can block all exports from a facility.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Cipla Limited Compare to Nearest Formoterol Exporters?
Exporters ranked immediately above and below #1 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 1 | CIPLA LIMITED ★ | $25.3M | 572 | 25 | $44.3K |
| 2 | MANKIND PHARMA LIMITED | $8.6M | 172 | 3 | $50.0K |
| 3 | SUN PHARMACEUTICAL INDUSTRIES LIMITED | $1.8M | 36 | 1 | $50.0K |
Cipla Limited ranks #1 among 153 Indian Formoterol exporters. Average shipment value of $44.3K compared to the market average of $255.0K. The closest competitors by value are MANKIND PHARMA LIMITED and SUN PHARMACEUTICAL INDUSTRIES LIMITED.
Which Indian Ports Ship Formoterol Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 898 | 18.3% |
| DELHI AIR | 817 | 16.6% |
| DELHI AIR CARGO ACC (INDEL4) | 758 | 15.4% |
| SAHAR AIR CARGO ACC (INBOM4) | 660 | 13.4% |
| NHAVA SHEVA SEA (INNSA1) | 322 | 6.5% |
| Delhi Air | 256 | 5.2% |
| Bombay Air | 139 | 2.8% |
| Bombay Air Cargo | 99 | 2.0% |
What Other Respiratory Products Does Cipla Limited Export?
Cipla Limited also exports these respiratory products. Each links to the detailed product page.
Geopolitical & Trade Policy Impact on Cipla Limited's Formoterol Exports
Cipla's export operations are currently navigating a complex geopolitical landscape. The Israel-Iran conflict has led to disruptions in Red Sea shipping routes, resulting in increased freight costs and extended transit times. These challenges are particularly acute for time-sensitive pharmaceutical shipments, necessitating strategic adjustments in logistics and supply chain management.
In the United States, recent import policies, including the imposition of 100% tariffs on branded or patented pharmaceutical products effective October 2025, have introduced additional hurdles for Indian exporters. While generic drugs, a significant component of Cipla's portfolio, may be less affected, the overall trade environment demands vigilance and adaptability. Conversely, the India-European Union Free Trade Agreement, concluded in January 2026, offers a promising avenue for Cipla. The agreement aims to eliminate tariffs on pharmaceuticals, potentially enhancing Cipla's competitiveness in the European market and offsetting challenges faced in other regions.
Cipla Limited — Regulatory Compliance & Quality Standards
Maintaining stringent quality standards is paramount for Cipla, given the diverse regulatory environments across its export markets. The company has demonstrated a strong commitment to compliance, as evidenced by the U.S. Food and Drug Administration's (FDA) classification of its Bengaluru facility as Voluntary Action Indicated (VAI) in October 2025. This classification is crucial for sustaining and expanding Cipla's presence in the U.S. market. Additionally, the European Union's evolving regulatory framework, including the Falsified Medicines Directive, necessitates continuous adaptation to ensure compliance and maintain market access.
About Cipla Limited
Cipla Limited exports 98 products worth $1.1B. Beyond Formoterol, top products include Fluticasone, Amlodipine, Salbutamol, Telmisartan, Salmeterol. View the complete Cipla Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Formoterol — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Formoterol shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Cipla Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 572 individual customs records matching Cipla Limited exporting Formoterol, covering 214 formulations to 27 countries via 55 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 81+ countries, 320+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Formoterol Export Data from Cipla Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Cipla Limited's Formoterol exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Cipla Limited
Full Company Profile →
98 products · $1.1B total trade · 26 categories
Formoterol Stats
Company Overview
Top Products by Cipla Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Cipla Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Formoterol. For current shipment-level data, contact TransData Nexus.